Evox Therapeutics
Latest round
- Series C
Last raised
- Feb 2021
Total raised
- $157M
Investors
- 9
About Evox Therapeutics
Founded in 2016 in Oxford, UK, Evox Therapeutics Limited specializes in exosome-based therapeutics for treating neurological disorders.Evox Therapeutics specializes in innovative therapeutics aimed at treating severe neurological and neurodegenerative diseases through its proprietary ExoEdit™ technology. The core product offerings involve an advanced CRISPR/Cas-based gene editing system encapsulated within exosome-based nanoparticles, allowing for targeted gene knockdown of mutations associated with various neurological disorders.90.Evox Therapeutics is dedicated to advancing its exosome-based therapeutics pipeline, particularly through the continuation of its DeliverEX platform aimed at rare diseases. The company is also looking to expand into new markets, specifically targeting North America and Europe for broader outreach in delivering treatments for neurological disorders.
Who invested in Evox Therapeutics
9 investors across 3 rounds
See all investors in Evox Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Evox Therapeutics
Who invested in Evox Therapeutics?
Evox Therapeutics has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Evox Therapeutics raised?
Evox Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Evox Therapeutics last raise money?
Evox Therapeutics's most recent round on record is a Series C, in Feb 2021.
What does Evox Therapeutics do?
Founded in 2016 in Oxford, UK, Evox Therapeutics Limited specializes in exosome-based therapeutics for treating neurological disorders.
Where is Evox Therapeutics headquartered?
Evox Therapeutics is headquartered in Oxford, UK.
Which VCs invest in companies like Evox Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Evox Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Evox Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.